Somalogic Inc (SLGC) - Total Assets
Based on the latest financial reports, Somalogic Inc (SLGC) holds total assets worth $565.05 Million USD as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SLGC net assets for net asset value and shareholders' equity analysis.
Somalogic Inc - Total Assets Trend (2019–2022)
This chart illustrates how Somalogic Inc's total assets have evolved over time, based on quarterly financial data.
Somalogic Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Somalogic Inc's total assets of $565.05 Million consist of 89.9% current assets and 10.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 65.2% |
| Accounts Receivable | $17.01 Million | 2.6% |
| Inventory | $13.90 Million | 2.2% |
| Property, Plant & Equipment | $19.56 Million | 3.0% |
| Intangible Assets | $16.70 Million | 2.6% |
| Goodwill | $10.40 Million | 1.6% |
Asset Composition Trend (2019–2022)
This chart illustrates how Somalogic Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Somalogic Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Somalogic Inc's current assets represent 89.9% of total assets in 2022, an increase from 83.9% in 2019.
- Cash Position: Cash and equivalents constituted 65.2% of total assets in 2022, up from 19.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is property, plant & equipment at 3.0% of total assets.
Somalogic Inc Competitors by Total Assets
Key competitors of Somalogic Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Pharmx Technologies Ltd
AU:PHX
|
Australia | AU$18.82 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
Australia | AU$1.64 Million |
|
Global Health Ltd
AU:GLH
|
Australia | AU$2.84 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$664.83K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
Somalogic Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.79 | 14.56 | 13.03 |
| Quick Ratio | 17.29 | 14.12 | 12.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $466.32 Million | $578.59 Million | $214.18 Million |
Somalogic Inc - Advanced Valuation Insights
This section examines the relationship between Somalogic Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.80 |
| Latest Market Cap to Assets Ratio | 0.61 |
| Asset Growth Rate (YoY) | -8.3% |
| Total Assets | $647.37 Million |
| Market Capitalization | $396.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Somalogic Inc's assets below their book value (0.61x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Somalogic Inc's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Somalogic Inc (2019–2022)
The table below shows the annual total assets of Somalogic Inc from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $647.37 Million | -8.32% |
| 2021-12-31 | $706.10 Million | +191.43% |
| 2020-12-31 | $242.29 Million | +240.00% |
| 2019-12-31 | $71.26 Million | -- |
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more